Aadi Bioscience, Inc. (AADI) has a consensus analyst rating of Buy, based on 6 analysts covering the stock. Of those, 3 recommend buying, 3 recommend holding, and 0 recommend selling.
The analyst consensus price target for AADI is $1.63, representing a -20.5% downside from the current price of $2.05. Price targets range from a low of $1.50 to a high of $1.75.
